Together, various studies have identified an important role of cysteine cathepsins in virion entry (Table 2) and suggest that inhibition of cathepsins, especially cathepsin L, could be an effective strategy for the search/development of new drugs for the treatment of COVID-19. This evidence concerns the gene CTSS and COVID-19.